This study details the suppressive mechanism involved in the antigen-specific suppression of collagen-induced arthritis. Intravenous injection of 500 
Introduction
A polyarthritis can be induced in specific strains of rats (1) or mice (2) by immunization with native homologous or heterologous type II collagen preparations. This animal model of proliferative synovitis is characterized by the development of both cellular and humoral immune responses to type II collagen (3, 4) . Collagen-induced arthritis (CIA)' can be adoptively transferred to naive rats by sensitized spleen cells (5) and passively transferred by immunoglobulin G specific for type II collagen (6) . These CIA can be modulated by free collagen and anti-collagen antiserum (7) . In addition, administration of collagen-coupled spleen cells (8) , native type II collagen (9) , or specific constituent CNBr peptides (10) before immunization with type II collagen results in the antigen specific suppression of CIA in rats. Rats administered collagen-coupled erythrocytes have also been utilized as splenic cell donors in studies showing the adoptive transfer of antigen-specific suppression of collagen arthritis (11) . However, the cell(s) responsible for this antigen-specific suppression have not been determined. The (6-12 wk of age) were purchased from Jackson Laboratory (Bar Harbor, ME).
Collagen purification. Native interstitial type I and type II collagens were isolated from pepsin digests of tissues rich in the particular isotype of collagen as described previously (12) . In brief, preparations of type I collagen were isolated from rabbit dermis and preparations of type II collagen were isolated from rabbit xyphoid process. Solubilized collagen was purified by differential salt precipitation from neutral salt or acid solutions (13). Collagen preparations were further purified by native state carboxymethylcellulose chromatography (for native type I collagen) and diethyleaminoethane cellulose chromatography (for native type II collagen) utilizing previously detailed conditions (14, 15) . Under these conditions, native interstitial collagen can be totally resolved from basement membranes or other related collagenous components as well as proteoglycan moieties. Assessment of purity was performed by molecule sieve, ion exchange chromatography, and 5% sodium method of Courtenay et al. (2) . In brief, 100 ,g of purified rabbit type 11 collagen emulsified in complete Freund's adjuvant (CFA) was injected intradermally at the base of the tail on day 0. A second identical injection of antigen emulsified in CFA was administered intraperitoneally on day 14. Mice were observed for onset of arthritis which, in general, occurred 4 wk after the initial injection. Animals were monitored daily for arthritis until they were killed. Preinoculation of antigen for suppression studies occurred 3 d before day 0. A single intravenous injection consisting of 500 Mg of native collagen (type I or type II) in 0.2 ml of isotonic saline was administered.
In parallel suppression studies, single intravenous injection of "25I-radiolabeled type II collagen (chloramine-T method [16] (50, 5 , and 0.5 Mg/ml) were added (20 ,ul) 
Results

Suppression of CIA in the mouse
Pathology. Initial experiments were performed to detail the suppression of CIA in the murine model of arthritis. Three groups of eight DBA/1J mice were preinoculated with 0.2 ml of phosphate-buffered saline, 500 Mg of native type I collagen, or 500 Mg of native type II collagen in 0.2 ml of phosphatebuffered saline and were subsequently immunized with type II collagen. The results obtained for the arthritis pathology score for these animals are summarized in Table I . Groups 1 and 2 (preinoculated with saline and type I collagen, respectively) were observed to have a high incidence of arthritis. With regard to gross pathology scoring, inflammation (erythema and edema) was most prominent in the hind paws with the left, on the average, more severe than the right. The corollary was observed for the forepaws with the right paw displaying a more severe, gross pathological condition, on the average, than the for the animals in group 3. In addition, these animals were observed to have very limited enlargement of terminal digits on the mildly inflamed paws.
The observed adoptive transfer of suppression of collageninduced arthritis by whole spleen cell populations derived from animals that were preinoculated with native type II collagen was noted to be dependent on the number of cells transferred via the tail vein. As shown in Table III (group 4) , 500,000 whole spleen cells adoptively transferred from native type II preinoculated-mice to naive animals resulted in the observation of collagen-induced arthritis in seven of nine mice tested. The individual inflammation pathology score ranged from 0 to 3, indicating a moderate inflammation particularly apparent in the left hind paw and right forepaw. The observed pathology scores for these animals were not observed to be statistically significant compared to the arthritic pathology scores observed for the animals from groups 1 and 2 in Table  III Further studies utilizing radiolabeled native type II collagen administered intravenously prior to adoptive transfer ruled out antigen carry-over during cell transfer as the mechanism of suppression. Although 1% of the administered radioactivity was observed in the spleen, <0.01% of administered radiolabel was noted in the single cell suspension of the splenic cells before injection. Fig. 1 , top panels, illustrates the hind paws of normal, arthritic (adoptively transferred spleen cells from saline-treated mice), and suppressed animals (adoptively transferred spleen cells from type II collagen-treated mice). Fig. 1, bottom (41) (42) (43) . As a general rule, these studies indicate that the larger the dose the greater degree of unresponsiveness and the longer its duration. Cell-transfer experiments (44) have shown that high-dose tolerance reflects unresponsiveness of both T helper cells (Lyl 2-) and B cells. Induction of a state of tolerance is also dependent on the time of presentation before or after antigenic challenge (9) . Investigations using extensive periods of time before or after challenge have reported difficulty in inducing tolerance (46, 47 
